(Date:11/8/2009)... The loss of a gene through deletion of genetic m...icant abnormalities in learning and behavior, said... of Medicine ( www.bcm.edu ) in a report that appe... , "This research goes about 95 percent of the w...f individuals to this gene," said Dr. Arthur L. Be...
(Date:11/6/2009)...wire/ -- Auburn Hills, MI-based Law Enforcement In...ts locker system and patent-pending Biometric Acce...t of Health and Human Services, National Institute...er system will support the NIH,s entire police for... medical research agency. The project is expected...
(Date:11/4/2009)...ntists are reluctant to officially endorse green t...es to grow about its protective effects, including...ntion Research , a journal of the American Associa...ction in oral cancer. , Vassiliki Papadimitrako...nt of Thoracic/Head and Neck Medical Oncology at t...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2U of C chemists discover recipe to design a better type of fuel cell 10405 1U of C chemists discover recipe to design a better type of fuel cell 10405 2Reeves College Prepares Campuses for H1N1 Virus 59702 1Reeves College Prepares Campuses for H1N1 Virus 59702 2Drinking Your Way to Health 3F Perhaps Not 59700 1Drinking Your Way to Health 3F Perhaps Not 59700 2Drinking Your Way to Health 3F Perhaps Not 59700 3(Date:11/6/2009)..., Calif., Nov. 6 Intarcia Therapeu...s ITCA 650 (DUROS® continuous delivery of exe...es at the Ninth Annual Diabetes Technology Meeting...wscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,...Via ITCA 650 Lowers Plasma Glucose, HbA1c and Redu...
(Date:11/5/2009)...ANY, N.J., Nov. 5 DSM Pharmaceutic...ufacturing alliance with Galenix, Saint Jean D,Ill...cial scale manufacturing partner for Galenix comme...lenix will collaborate on business development opp...nologies, based on the strength of Galenix in drug...
(Date:11/5/2009)...K, N.Y., Nov. 5 BioSpeci...rmaceutical company developing first-in-class coll...ial results for the third quarter ended September ... September of this year, the FDA,s Arthritis Advis...f 12-0, the approval of XIAFLEX(TM) for the treatm...
(Date:11/5/2009)... Texas, Nov. 5 SpineSmith Partners...c. to co-develop a unique scaffold that mimics the...evaluation of several commercial products by Spine...ompany believes the GenOsteo scaffold represents a...s a unique and ideal environment for the delivery ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2...LE, Calif., Nov. 20 Cepheid (Nasdaq:,CPHD) will p... Conference,on November 27 at 9 a.m. ET at The Pie...tive Officer, and John R. Sluis, Senior Vice Presi...vide a corporate overview. The webcast, along wit...cessed on Cepheid,s Web site at http://www.cephei...
...E, Mass., Nov. 20 NxStage Medical,Inc. (Nasdaq: ...sis,products, today announced that Jeffrey H. Burb...he 19th Annual Piper Jaffray Healthcare Conference...of the Company at 2:30 p.m.,Eastern Time on Tuesda...rk,City. To listen to the audio web cast of the p...
...Israel, November 20 - Third quarter Consolidated...llion Last Year; Third Quarter 2006 Results Advers...blishing Today Hebrew Draft Prospectus for the Iss...e Strategic Plan; Debentures,Were Rated AA Stable ...Refineries Ltd. (TASE: ORL) ("Oil Refineries" or t...
Other Biology Technology:Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference 2NxStage Medical to Present at the Piper Jaffray Healthcare Conference on November 27, 2007 2Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 2Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 3Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 4Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 5Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 6Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 7Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 8Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 9Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 10Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 11pORF-eSEAP from InvivoGen
...s have triple baffles located at the center of the...o culture medium. These flasks have a large markin...le for these bottles including:, Polypropylene co..., Vented membrane cap with 0.22m PTFE hydrophobic ...
...NA samples., , This product has been optimised... have been pre-purified using traditional methods ...o dT etc or other kits. , Our StabMRT Kits conta...ion of nanogram to milligram quantities of RNA. ,...
SkanWasher 400 from Molecular Devices
Biology Products: